A venture arm of an innovation hub headquartered in California for life science, medtech, and technology companies invests in Pre-Seed and Seed stage biotech, device, and ag-tech companies in the U.S. The firm acts as a lead investor. For Pre-Seed rounds, typical check size falls between $250k-1M and for Seed rounds, typical check size falls between $1M-3M. For their main fund, it is not required for companies to go through the accelerator program, however the resources are available and encouraged
In terms of life sciences and healthcare, the firm is interested in biotech and medical devices. For biotech, the firm is subsector agnostic, including drug development and bio tools, for device, the firm is open to all classes. The firm is also indication-agnostic. The firm typically looks at companies in pre-clinical stages.
The firm requires companies to already be incorporated and have their CEOs to be fulltime. The firm may take a board seat on a case-by-case basis.
If you are interested in more information about this investor and other investors tracked by LSN, please email salescore@lifesciencenation.com.
Next Phase Newsletter 
Leave a comment